Table 3 Mean time interval in days between injections of aflibercept and ranibizumab in the months 1–12 following incident treatment
Intervall | Ranibizumab (mean) | Ranibizumab (median) | Ranibizumab (N) | Aflibercept (mean) | Aflibercept (median) | Aflibercept (N) | p-Wert |
|---|---|---|---|---|---|---|---|
1 | 40.2 | 28 | 2051 | 42.3 | 30 | 737 | 0.054 |
2 | 40.9 | 29 | 1847 | 40.4 | 30 | 694 | 0.104 |
3 | 60.4 | 42 | 1419 | 64.8 | 49 | 549 | < 0.001 |
4 | 48.4 | 35 | 1167 | 55.6 | 46 | 478 | < 0.001 |
5 | 46.3 | 35 | 971 | 48.0 | 42 | 417 | 0.002 |
6 | 50.4 | 42 | 733 | 51.8 | 42 | 321 | 0.088 |
7 | 40.6 | 35 | 564 | 44.1 | 42 | 234 | 0.006 |
8 | 37.3 | 35 | 415 | 40.1 | 42 | 157 | 0.001 |
9 | 33.3 | 31 | 265 | 34.6 | 33.5 | 92 | 0.413 |